
APLLTDAlembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹334 Crore on Total Income of ₹2,619 Crore
Alembic Pharmaceuticals (NSE: APLLTD) reported consolidated total income of ₹2,618.59 crore and net profit of ₹333.91 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹2,416.07 crore and standalone net profit ₹409.36 crore for the same quarter.
- Earnings
- pharmaceuticals